In Silico Investigation of the Pharmacological Mechanisms of Beneficial Effects of Ginkgo biloba L. on Alzheimer’s Disease
Open Access
Abstract
Based on compelling experimental and clinical evidence, Ginkgo biloba L. exerts a beneficial effect in ameliorating mild to moderate dementia in patients with Alzheimer’s disease (AD) and other neurological disorders, although the pharmacological mechanisms remain unknown. In the present study, compounds, their putative target proteins identified using an inverse docking approach, and clinically tested AD-related target proteins were systematically integrated together with applicable bioinformatics methods in silico. The results suggested that the beneficial effects of G. biloba on AD may be contributed by the regulation of hormone sensitivity, improvements in endocrine homeostasis, maintenance of endothelial microvascular integrity, and proteolysis of tau proteins, particularly prior to amyloid β-protein (Aβ) plaque formation. Moreover, we identified six putative protein targets that are significantly related to AD, but have not been researched or have had only preliminary studies conducted on the anti-AD effects of G. biloba. These mechanisms and protein targets are very significant for future scientific research. In addition, the existing mechanisms were also verified, such as the reduction of oxidative stress, anti-apoptotic effects, and protective effects against amyloidogenesis and Aβ aggregation. The discoveries summarized here may provide a macroscopic perspective that will improve our understanding of the molecular mechanism of medicinal plants or dietary supplements, as well as new clues for the future development of therapeutic strategies for AD.Keywords
Funding Information
- CAMS Innovation Fund for Medical Sciences (CIFMS 2016-I2M-1-012)
- Guangxi Science and Technology Foundation and Talents Project (Gui Ke AD17129044)
This publication has 61 references indexed in Scilit:
- Adipokine pathways are altered in hippocampus of an experimental mouse model of Alzheimer's diseaseThe Journal of nutrition, health and aging, 2015
- Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 DiabetesArchives of Neurology, 2011
- Multifunctional roles of gelsolin in health and diseasesMedicinal Research Reviews, 2010
- Diabetes Type II: A Risk Factor for Depression–Parkinson–Alzheimer?Neurotoxicity Research, 2010
- Neuroprotective effects of Ginkgo biloba extractCellular and Molecular Life Sciences, 2003
- Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small moleculeProteins: Structure, Function, and Bioinformatics, 2001
- Extracts of ginkgo biloba leaves inhibit monoamine oxidaseLife Sciences, 1996
- Age-related change in redox state of human serum albuminBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995
- Neutral endopeptidase can hydrolyze β-amyloid(1–40) but shows no effect on β-amyloid precursor protein metabolismPeptides, 1995
- In situ hybridization of oxytocin messenger RNA: Macroscopic distribution and quantitation in rat hypothalamic cell groupsBiochemical and Biophysical Research Communications, 1987